BRAF and colorectal carcinoma: Figures 2C and S1 also further establish that, although less efficient than in DLD-1 cells, this effect was evidenced in all the CRC cell lines tested, whatever their mutational status for SOX9, APC, ß-catenin KRAS or BRAF (Figure S3).